Kyle Birnbaum focuses his practice on general corporate and securities law, with an emphasis on the representation of emerging growth companies and venture capital funds. In addition, he provides counsel on day-to-day corporate governance issues and other legal matters.

Download full bio 


  • EyePoint Pharmaceuticals – $115.4 Million Follow-on Offering 

  • CinCor Pharma – $212 Million IPO 


  • George Washington University Law School
    JD, with honors, 2019

  • Union College
    BA, Economics
    summa cum laude, 2015

Admissions & Credentials

New York